Free Trial
NASDAQ:HSDT

Helius Medical Technologies Q1 2025 Earnings Report

Helius Medical Technologies logo
$4.59 +0.69 (+17.65%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$4.61 +0.02 (+0.41%)
As of 05/2/2025 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Helius Medical Technologies EPS Results

Actual EPS
-$0.51
Consensus EPS
-$0.58
Beat/Miss
Beat by +$0.07
One Year Ago EPS
N/A

Helius Medical Technologies Revenue Results

Actual Revenue
$0.05 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Helius Medical Technologies Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Thursday, May 1, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Helius Medical Technologies' Q2 2025 earnings is scheduled for Monday, May 12, 2025

Earnings Documents

Helius Medical Technologies Earnings Headlines

Donald Trump is about to free crypto from its chains …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.
Helius Medical Technologies Announces Reverse Stock Split
See More Helius Medical Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Helius Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Helius Medical Technologies and other key companies, straight to your email.

About Helius Medical Technologies

Helius Medical Technologies (NASDAQ:HSDT), a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

View Helius Medical Technologies Profile

More Earnings Resources from MarketBeat